Status:
COMPLETED
Scleroderma Registry
Lead Sponsor:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborating Sponsors:
The University of Texas Health Science Center, Houston
Conditions:
Systemic Sclerosis
Scleroderma
Eligibility:
All Genders
18-70 years
Brief Summary
Scleroderma is likely caused by a combination of factors, including an external trigger (infection or other exposure) and a genetic predisposition. The Scleroderma Registry will conduct genetic analys...
Detailed Description
Scleroderma refers to a group of diseases that involve the abnormal growth of connective tissue, which supports the skin and internal organs. Scleroderma can affect the skin, making it hard and tight;...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Diagnosis of systemic sclerosis or family members of patients with systemic sclerosis
- Or
- Healthy volunteer with no autoimmune disease and without a first-degree relative with a systemic autoimmune disease
Exclusion
Key Trial Info
Start Date :
September 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT00074568
Start Date
September 1 2000
End Date
January 1 2022
Last Update
September 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas - Houston Medical School
Houston, Texas, United States, 77030